MML Investors Services
RPRX icon

MML Investors Services’s Royalty Pharma RPRX Stock Holding History

MML Investors Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
49,942
+7,673
+18% +$399K 0.01% 1335
2026
Q1 		$2.03M Buy
42,269
+5,658
+15% +$248K 0.01% 1311
2025
Q4 		$1.41M Buy
36,611
+11,304
+45% +$431K ﹤0.01% 1587
2025
Q3 		$893K Buy
+25,307
New +$916K ﹤0.01% 1810
2025
Q1 		– Sell
-46,800
Closed -$1.19M – 2787
2024
Q4 		$1.19M Buy
+46,800
New +$1.24M ﹤0.01% 1396

Other funds holding RPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.28B AUM 47.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return

MML Investors Services's RPRX Position: Q2 2026 in Review

MML Investors Services increased its Royalty Pharma (RPRX) stake by 18% in Q2 2026, buying an estimated $399K and bringing the position to 49,942 shares worth $2.8M. The position accounts for 0.01% of the portfolio, ranked #1335.

MML Investors Services first reported a position in RPRX in Q4 2024 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • MML Investors Services held 49,942 shares of Royalty Pharma worth $2.8M as of Q2 2026.
  • MML Investors Services bought 7,673 Royalty Pharma shares in Q2 2026, an estimated $399K.
  • Royalty Pharma made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1335 holding.
  • MML Investors Services first reported a position in Royalty Pharma in Q4 2024 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.